Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics.

MLA

Boylan, Kristin L. M., et al. “Evaluation of the Potential of Pap Test Fluid and Cervical Swabs to Serve as Clinical Diagnostic Biospecimens for the Detection of Ovarian Cancer by Mass Spectrometry-Based Proteomics.” Clinical Proteomics, vol. 18, no. 1, Jan. 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12014-020-09309-3.

APA

Boylan, K. L. M., Afiuni-Zadeh, S., Geller, M. A., Argenta, P. A., Griffin, T. J., & Skubitz, A. P. N. (2021). Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics. Clinical Proteomics, 18(1), 1–12. https://doi.org/10.1186/s12014-020-09309-3

Chicago

Boylan, Kristin L. M., Somaieh Afiuni-Zadeh, Melissa A. Geller, Peter A. Argenta, Timothy J. Griffin, and Amy P. N. Skubitz. 2021. “Evaluation of the Potential of Pap Test Fluid and Cervical Swabs to Serve as Clinical Diagnostic Biospecimens for the Detection of Ovarian Cancer by Mass Spectrometry-Based Proteomics.” Clinical Proteomics 18 (1): 1–12. doi:10.1186/s12014-020-09309-3.